Magnolia Medical Technologies is a device development company that focuses on improving the accuracy of diagnostic blood culture tests.
Magnolia Medical Technologies is a device development company that focuses on improving the accuracy of diagnostic blood culture tests. It has developed a wide range of products to significantly improve diagnostic specimen quality aimed at directly and dramatically increasing diagnostic accuracy for critical laboratory tests. The company’s intellectual property portfolio includes more than 70 issued patents with more than 50 additional patent applications pending.It was incorporated in 2011 and is based in Seattle, Washington.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 27, 2020 | Debt Financing | $20M | 1 | Horizon Technology Finance | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Horizon Technology Finance | Yes | Debt Financing |